Thomas A Sellers

Title: Thomas A. Sellers: A Pioneer in Breast Cancer Research and Genotyping Innovations

Introduction

Thomas A. Sellers is a distinguished inventor based in Tampa, FL, who has made significant contributions to the field of medical research, particularly in breast cancer and prostate cancer diagnostics. With an impressive portfolio of seven patents, Sellers has demonstrated a commitment to innovation and improving patient outcomes through advanced methodologies.

Latest Patents

Two of Sellers’ notable recent patents focus on critical advancements in cancer detection and risk assessment. The first patent addresses the Breast Imaging Reporting and Data System (BI-RADS) tissue composition. This invention introduces a methodology for converting continuous measurements of breast density from mammograms into a four-state ordinal variable that aligns with BI-RADS ratings. The calibration system designed for specific full-field digital mammography (FFDM) technology compensates for variations in x-ray acquisition techniques across different mammograms. This results in standardized imaging and has produced various calibrated measures of breast density, including an assessment of variation referred to as Vc.

The second patent revolutionizes prostate cancer treatment by disclosing a method for determining cancer recurrence using polymorphisms in angiogenesis-related genes. This method involves genotyping a nucleic acid sample from patients for specific SNP alleles, comparing them to control frequencies to produce a SNP signature, and generating a risk score that indicates the likelihood of cancer recurrence following surgery. A high risk score in patients with positive margins points to a greater risk of recurrence, offering vital information for patient management.

Career Highlights

Throughout his career, Thomas A. Sellers has contributed to notable research institutions, including the H. Lee Moffitt Cancer Center and Research Institute and the Mayo Foundation for Medical Education and Research. His work has significantly impacted the understanding and treatment of breast and prostate cancer, showcasing his dedication to advancing medical technologies.

Collaborations

Collaborating with esteemed professionals, including John J. Heine and Erin E. Fowler, Sellers has fostered an environment of innovation and research excellence. These partnerships have further enhanced the quality and impact of his inventions, paving the way for breakthroughs in cancer diagnostics and therapy.

Conclusion

Thomas A. Sellers stands out as a valuable inventor whose innovations may change the landscape of cancer treatment and risk assessment. His commitment to excellence and collaboration has resulted in patents that not only enhance diagnostic methodologies but also provide essential insights into cancer management. As research in this field continues to evolve, Sellers' contributions will undoubtedly play a critical role in shaping the future of cancer care.